NCT00004747View on ClinicalTrials.gov

Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

July 31, 1995

Conditions
Cystic FibrosisBacterial Infections
Interventions
DRUG

mucoid exopolysaccharide P. aeruginosa immune globulin IV

All Listed Sponsors
collaborator

Vanderbilt University Medical Center

OTHER

lead

National Center for Research Resources (NCRR)

NIH